1. Home
  2. IRTC

as 06-20-2025 4:00pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Founded: 2006 Country:
United States
United States
Employees: N/A City: San Francisco
Market Cap: 4.5B IPO Year: 2016
Target Price: $138.60 AVG Volume (30 days): 469.1K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.14 EPS Growth: N/A
52 Week Low/High: $55.92 - $150.00 Next Earning Date: 07-31-2025
Revenue: $618,587,000 Revenue Growth: 20.54%
Revenue Growth (this year): 19.91% Revenue Growth (next year): 16.81%

IRTC Daily Stock ML Predictions

Stock Insider Trading Activity of iRhythm Technologies Inc. (IRTC)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Patterson Chad IRTC Chief Commercial Officer Jun 10 '25 Sell $150.00 363 $54,450.00 49,865
Shrishrimal Sumi IRTC EVP, Chief Risk Officer May 30 '25 Sell $140.21 1,608 $225,457.68 34,685
Patterson Chad IRTC Chief Commercial Officer May 2 '25 Sell $122.38 8,510 $1,025,897.50 49,865
Wilson Daniel G. IRTC Chief Financial Officer May 2 '25 Sell $125.00 2,000 $250,000.00 43,307

Share on Social Networks: